Search Results - "Kegg, S"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Bone mineral density, kidney function, weight gain and insulin resistance in women who switch from TDF/FTC/NNRTI to ABC/3TC/DTG by Ibrahim, F, Samarawickrama, A, Hamzah, L, Vincent, R, Gilleece, Y, Waters, L, Kegg, S, Barbini, B, Campbell, L, Post, FA

    Published in HIV medicine (01-02-2021)
    “…Objectives Tenofovir disoproxil fumarate (TDF) is associated with reduced bone mineral density (BMD). We evaluated changes in BMD in women who switched from…”
    Get full text
    Journal Article
  2. 2

    HIV in prisons: the London experience by Natha, M, Kegg, S, Spice, W, Hadfield, J, Kelly, B, Lau, R, Pakianathan, M

    Published in International journal of STD & AIDS (01-04-2008)
    “…The commissioning of health services for all prisoners in publicly run prisons in England was transferred to local Primary Care Trusts in April 2006, pledging…”
    Get more information
    Journal Article
  3. 3
  4. 4
  5. 5

    The risk of viral rebound in the year after delivery in women remaining on antiretroviral therapy by Huntington, Susie, Thorne, Claire, Newell, Marie-Louise, Anderson, Jane, Taylor, Graham P, Pillay, Deenan, Hill, Teresa, Tookey, Pat A, Sabin, Caroline

    Published in AIDS (London) (01-11-2015)
    “…The objective of this study is to assess the risk of viral rebound in postpartum women on suppressive combination antiretroviral therapy (cART). Using data…”
    Get full text
    Journal Article
  6. 6

    Pregnant … pause? Is there a difference in the long‐term outcome of women starting ART for the first time in pregnancy? by Farne, H, Russell, J, Kegg, S

    Published in Journal of the International AIDS Society (01-11-2012)
    “…Purpose of the study The guidelines on the initial choice of antiretroviral therapy (ART) in women starting ART for the first time in pregnancy have changed…”
    Get full text
    Journal Article
  7. 7

    Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapy by Huntington, Susie, Thorne, Claire, Newell, Marie-Louise, Anderson, Jane, Taylor, Graham P, Pillay, Deenan, Hill, Teresa, Tookey, Pat A, Sabin, Caroline

    Published in AIDS (London) (24-04-2015)
    “…The objective of this study is to assess whether pregnancy is associated with an increased risk of liver enzyme elevation (LEE) and severe LEE in HIV-positive…”
    Get full text
    Journal Article
  8. 8

    Tamoxifen in antiretroviral-associated gynaecomastia by Kegg, Stephen, Lau, Richard

    Published in International journal of STD & AIDS (01-08-2002)
    “…Gynaecomastia arising in the context of antiretroviral therapy for HIV infection presents a number of challenges in diagnosis and management. We describe a…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Menstrual cycle and oral contraceptive effects on alcohol pharmacokinetics in caucasian females by Zeiner, A R, Kegg, P S

    Published in Currents in alcoholism (1981)
    “…We investigated the relationship between oral contraceptives, day of menstrual cycle and alcohol pharmacokinetics in 20 Caucasian females. Peak blood alcohol…”
    Get more information
    Journal Article
  11. 11

    Gender differences in peak acetaldehyde concentration after an acute dose of ethanol by Zeiner, A R, Kegg, P S, Blackburn, M, Stratton, R

    Published in Neurobehavioral toxicology and teratology (01-03-1983)
    “…Acetaldehyde, the first metabolite of ethyl alcohol, is found in higher concentrations in alcoholics and heavy drinkers after alcohol ingestion than in social…”
    Get more information
    Journal Article
  12. 12

    Effects of sex steroids on ethanol pharmacokinetics and autonomic reactivity by Zeiner, A R, Kegg, P S

    “…Several lines of evidence indicate that female sex steroids, especially estrogen, interact with ethanol pharmacokinetics. Both animal and human studies are…”
    Get more information
    Journal Article
  13. 13
  14. 14